Author

Ying Xiao

Institution: University of Pennsylvania

Observed institution: University of Pennsylvania

OpenAlex ID: A5136866034

NRG-GY037: A phase III randomized trial of induction chemotherapy and pembrolizumab followed by chemoradiation and pembrolizumab maintenance versus standard chemoradiation and pembrolizumab maintenance in high-risk locally advanced cervical cancer.

2026 · Jyoti Mayadev, Wei Deng, et al. · Journal of Clinical Oncology · 1

Radiation Quality and Workflow in NRG GY017: Anti-PD-L1 (Atezolizumab) as an Immune Primer or Concurrently With Radiation Therapy for Node-Positive Locally Advanced Cervical Cancer

2026 · Jyoti Mayadev, Wei Deng, et al. · International Journal of Radiation Oncology*Biology*Physics

Works count: 2

Citation count: 1

H-index: 1

I10-index: